OHSU in the news

OHSU doc: COVID could spike, flu season strong

KOIN-TV October 24, 2022
In an interview with KOIN-TV, Peter Graven, Ph.D., says predictors show a potentially severe flu season and suggests people get both the flu shot and COVID booster.

Fears of US ‘twindemic’ of flu, RSV grow with or without COVID-19

The Hill October 24, 2022
The Hill covers the potential for a “twindemic” as the nation deals with children’s hospitals crowded with cases of respiratory syncytial virus (RSV) and the flu. The article includes a statement from Doernbecher Children's Hospital: “The best thing parents can do to keep their kids and themselves healthy and safe are to keep doing all their good handwashing and precautions we’ve learned over the last couple years when people are sick, as well as getting their flu vaccines and bivalent COVID boosters when they are able.

FDA approves upadacitinib for non-radiographic axial spondyloarthritis

Healio Rheumatology October 22, 2022
In response to FDA approval of upadacitinib for the treatment of non-radiographic axial spondylarthritis, Atul Deodhar, M.D., says "Today's FDA approval offers an important new therapeutic option for patients and their caregivers to help take control of their symptoms and disease."

Medical-dental integration emphasizes mouth-body connection

ADA News October 21, 2022
In a story about dentists and physicians collaborating to improve patient health, Gary Stafford, D.M.D., describes how OHSU School of Dentistry faculty and students collaborate with other health professionals at OHSU dental clinics as well as through interprofessional education and while giving COVID-19 and flu vaccines.

OHSU Knight Cancer Institute: Breast Cancer Screenings

KATU-TV October 21, 2022
In an interview for KATU-TV's AM Northwest, Evie Hobbs, M.D., discusses the importance of mammograms and early detection for breast cancer. She says, “What we know is that early detection is so incredibly important in catching breast cancer early so that we can provide treatment to reduce the risk of recurrence.”
See more stories